EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation

Chiara Leotta, Leah Hernandez iD, Lubomira Tothova iD, Samsul Arefin iD, Paola Ciceri, Mario Gennaro Cozzolino iD, Peter Barany, Milan Chromek iD, Peter Stenvinkel iD, Karolina Kublickiene iD

Cells · 06.12.2023 · 12 (24) · 2774

DOI: 10.3390/cells12242774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 06.12.2023. Verfasst von Chiara Leotta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 17177 Stockholm, Sweden. Hauptthemen laut MEDLINE: Kidney Transplantation, Cell-Free Nucleic Acids, Kidney Failure, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GOING-FWD Consortium, CIMED, Heart and Lung Foundation, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating cell-free DNA (cfDNA) has diverse applications in oncological, prenatal, toxicological, cardiovascular, and autoimmune diseases, diagnostics, and organ transplantation. In particular, mitochondrial cfDNA (mt-cfDNA) is associated with inflammation and linked to early vascular ageing (EVA) in end-stage kidney failure (ESKF), which could be a noninvasive marker for graft rejection and organ damage. Plasma samples from 44 ESKF patients, of whom half (n = 22) underwent either conservative therapy (non-HD) or hemodialysis (HD) before kidney transplantation (KT). These samples were analyzed at baseline and two years after KT. cfDNA was extracted from plasma and quantified using the fluorometric method. qPCR was used to quantify and differentiate the fractions of mt-cfDNA and nuclear cfDNA (nc-cfDNA). mt-cfDNA levels in KT patients decreased significantly from baseline to two years post-KT (p < 0.0268), while levels of total cfDNA and nc-cfDNA did not differ. Depending on therapy modality (HD vs. non-HD) before KT, total cfDNA levels were higher in HD patients at both baseline (p = 0.0133) and two years post-KT (p = 0.0421), while nc-cfDNA levels were higher in HD only at baseline (p = 0.0079). Males showed a nonsignificant trend of higher cfDNA levels. Patients with assessed vascular fibrosis (p = 0.0068), either alone or in combination with calcification plus fibrosis, showed reduced mt-cfDNA post-KT (p = 0.0195). Changes in mt-cfDNA levels suggests the impact of KT on the inflammatory state of ESKF, as evidenced via its correlation with high sensitivity C-reactive protein after KT. Further studies are warranted to assess if cfDNA could serve as a noninvasive method for monitoring the response to organ transplantation and even for amelioration of EVA status per se.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCell-Free Nucleic AcidsKidney Failure, ChronicMaleHumansRenal DialysisFibrosis

Stichwörter der Autor:innen

cell-free DNAend-stage kidney failurehemodialysiskidney transplantationsex difference

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Division of Renal Medicine, Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 17177 Stockholm, Sweden.
  • Renal Division, Department of Health Sciences, ASST Santi Paolo e Carlo Hospital Milan, University of Milan, 20142 Milan, Italy.
  • Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia.
  • Division of Pediatrics, Clinical Science, Intervention and Technology (CLINTEC), Karolinska University Hospital, 17177 Stockholm, Sweden.

ORCID-Profile: Leah Hernandez, Lubomira Tothova, Samsul Arefin, Mario Gennaro Cozzolino, Milan Chromek, Peter Stenvinkel, Karolina Kublickiene

Förderung

  • GOING-FWD Consortium
  • CIMED, Heart and Lung Foundation
  • Swedish Research Council
  • The Slovak Research and Development Agency
  • the Grant Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic

Zitieren

APA

Leotta, C., Hernandez, L., Tothova, L., Arefin, S., Ciceri, P., Cozzolino, M. G., Barany, P., Chromek, M., Stenvinkel, P., & Kublickiene, K. (2023). Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation. Cells, 12(24), 2774. https://doi.org/10.3390/cells12242774

Vancouver

Leotta C, Hernandez L, Tothova L, Arefin S, Ciceri P, Cozzolino MG, et al. Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation. Cells. 2023;12(24):2774. doi:10.3390/cells12242774

BibTeX
@article{Leotta2023,
  author = {Leotta, Chiara and Hernandez, Leah and Tothova, Lubomira and Arefin, Samsul and Ciceri, Paola and Cozzolino, Mario Gennaro and Barany, Peter and Chromek, Milan and Stenvinkel, Peter and Kublickiene, Karolina},
  title = {Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {24},
  pages = {2774},
  doi = {10.3390/cells12242774}
}
Kostenlos starten →